Myopia Control by Combining Auricular Acupoint and Atropine Eyedrops
|ClinicalTrials.gov Identifier: NCT00457717|
Recruitment Status : Completed
First Posted : April 6, 2007
Last Update Posted : April 6, 2007
|Condition or disease||Intervention/treatment||Phase|
|Myopia||Drug: 0.25 % atropine Drug: 0.5 % atropine Procedure: 0.25 % atropine+auricular acupoints||Phase 1|
A total of 64 school-aged children with myopia, fulfilling eligibility criteria, were recruited. They were randomly assigned to three arms:
- 21 treated with the 0.25 % atropine each night (0.25A).
- 20 treated with the 0.5 % atropine each night (0.5A).
- 23 treated with 0.25 % atropine each night together with stimulation of auricular acupoints(0.25A+E).
This protocol was proceeded for at least 6 months.The differences in post-treatment effects of these three groups were statistically accessed.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Study Start Date :||July 2005|
|Study Completion Date :||July 2006|
- the progression of myopia degree, axial length elongation of eye
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00457717
|China Medical University|
|Taichung City, Taiwan|
|Principal Investigator:||Shih-Liang Chang, PhD||China Medical University, Taiwan|